DB00039 | Palifermin | approved | unknown | agonist | Details |
DB05014 | XL999 | investigational | unknown | | Details |
DB07525 | 3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine | experimental | unknown | | Details |
DB07840 | (E)-[4-(3,5-Difluorophenyl)-3H-pyrrolo[2,3-b]pyridin-3-ylidene](3-methoxyphenyl)methanol | experimental | unknown | | Details |
DB08577 | 3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE | experimental | unknown | | Details |
DB02058 | 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone | experimental | unknown | | Details |
DB08896 | Regorafenib | approved | yes | inhibitor | Details |
DB08901 | Ponatinib | approved, investigational | unknown | inhibitor | Details |
DB00398 | Sorafenib | approved, investigational | yes | inhibitor | Details |
DB09078 | Lenvatinib | approved, investigational | yes | inhibitor | Details |
DB09079 | Nintedanib | approved | yes | inhibitor | Details |
DB01109 | Heparin | approved, investigational | unknown | | Details |
DB12010 | Fostamatinib | approved, investigational | unknown | inhibitor | Details |
DB12147 | Erdafitinib | approved, investigational | yes | inhibitor | Details |
DB15102 | Pemigatinib | approved, investigational | yes | inhibitor | Details |
DB15685 | Selpercatinib | approved, investigational | unknown | inhibitor | Details |
DB15822 | Pralsetinib | approved, investigational | unknown | inhibitor | Details |
DB11800 | Tivozanib | approved, investigational | unknown | inhibitor | Details |
DB11886 | Infigratinib | approved, investigational | yes | inhibitor | Details |
DB15149 | Futibatinib | approved, investigational | yes | inhibitor | Details |